Candidal sepsis is a severe, life-threatening systemic infection caused by the presence of Candida species in the bloodstream (candidemia) leading to acute organ dysfunction. This condition represents a critical failure of the host immune system to contain the fungal pathogen, resulting in a dysregulated inflammatory response. Unlike localized candidiasis, candidal sepsis requires aggressive intravenous antifungal therapy and intensive care support. It is a major cause of morbidity and mortality in hospitalized patients, particularly those with central venous access, receiving total parenteral nutrition (TPN), or undergoing prolonged broad-spectrum antibiotic therapy. The pathogen most frequently isolated is Candida albicans, though non-albicans species such as Candida glabrata, Candida parapsilosis, and the multidrug-resistant Candida auris are increasingly prevalent in clinical settings. The infection often seeds to secondary sites such as the eyes (endophthalmitis), heart (endocarditis), and kidneys, necessitating thorough screening once the bloodstream infection is identified.
Explicitly distinguish between candidemia and candidal sepsis to ensure accurate severity capturing.
Example: Patient presenting with systemic inflammatory response syndrome (SIRS) due to Candida albicans fungemia, evidenced by hypotension (MAP 55 mmHg) and acute renal failure. Diagnosis: Candidal sepsis with associated septic shock and acute kidney injury.
Billing Focus: Identify the causative organism (Candida albicans) and the systemic manifestation (sepsis).
Document the presence of any associated acute organ dysfunction to justify the use of severe sepsis codes.
Example: 65-year-old male with candidal sepsis secondary to Candida glabrata. Patient exhibits acute respiratory failure requiring mechanical ventilation. Documentation supports R65.20 (Severe sepsis) as a secondary code.
Billing Focus: Sequencing B37.7 as the primary diagnosis followed by R65.20 and specific organ failure codes (e.g., J96.01).
Clarify the relationship between candidal sepsis and indwelling devices such as central venous catheters.
Example: Candidal sepsis (Candida parapsilosis) documented as a complication of an infected peripherally inserted central catheter (PICC). Note includes code T80.211A for infection due to central venous catheter.
Billing Focus: Use of complication codes (T-codes) as secondary diagnoses when the sepsis is linked to a medical device.
Specify the clinical criteria used for the sepsis diagnosis, such as Sepsis-3 (SOFA score) or Sepsis-2 (SIRS).
Example: Patient meets Sepsis-3 criteria with a SOFA score increase of 3 points (baseline 0) in the setting of Candida krusei blood cultures. Diagnosis: Candidal sepsis.
Billing Focus: Provides clinical validation for the diagnosis to prevent denials based on lack of clinical indicators.
Document the acuity of the patient, specifically noting if the sepsis has progressed to septic shock.
Example: Candidal sepsis (Candida albicans) with septic shock. Patient remains hypotensive despite aggressive fluid resuscitation (30mL/kg) and now requires norepinephrine at 0.1 mcg/kg/min.
Billing Focus: Requires R65.21 (Severe sepsis with septic shock) to be coded as an additional diagnosis.
Candidal sepsis often requires constant physician attendance for hemodynamic instability.
Used for follow-up management of a patient recovering from candidal sepsis in the outpatient setting.
Reserved for unstable post-sepsis patients with multiple comorbidities and complex antifungal regimens.
Appropriate for routine check-ins for stable patients on oral antifungal step-down therapy.
Gold standard for diagnosing candidal sepsis/candidemia.
Rapidly identifies Candida species to guide early targeted antifungal therapy.
Required for the initial workup and stabilization of a patient suspected of fungal sepsis.
Infectious disease consultation is standard of care for candidemia/candidal sepsis.